Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Zyme Communications

08:28 EDT 16th October 2018 | BioPortfolio

Here are the most relevant search results for "Zyme Communications" found in our extensive news archives from over 250 global news sources.

More Information about Zyme Communications on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Zyme Communications for you to read. Along with our medical data and news we also list Zyme Communications Clinical Trials, which are updated daily. BioPortfolio also has a large database of Zyme Communications Companies for you to search.

Showing News Articles 1–25 of 377 from Zyme Communications

Tuesday 16th October 2018

Arcis Biotechnology and Teleflex sign license agreement

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK, 16 October 2018: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis&rs...

Monday 15th October 2018

Applied Photophysics signs distribution agreement with Particular Sciences to expand coverage in Europe

Distributor will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Ireland and Northern Ireland Surrey, UK and Dublin, IRELAND, 15 October 2018: Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced that it has signed a distribution agreement with material characterisation specialist, Partic...

Evonetix named Best Synthetic Biology Company at OBN Awards

Prestigious business award granted in recognition of novel gene synthesis technology CAMBRIDGE, UK, 12 October 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has received the award for “Best Emerging Synthetic Biology Company” at the 10th Anniversary of the Oxford Bio...

Friday 12th October 2018

Diamond Pharma Services named Best Specialist CRO at OBN Awards

Prestigious business award granted in recognition of expert services in cell and gene therapy Harlow, Essex, UK, 12 October 2018 – Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received the award for “Best Specialist ...

Wednesday 10th October 2018

Avacta agrees Affimer reagent licensing deal with New England Biolabs

Royalty bearing license agreement to commercialise a product incorporating the Affimer technology Wetherby and Cambridge, UK, 10 October 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswich MA, USA), a global leader in the discovery and...

ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

Funding will be used to improve efficiency of induced pluripotent stem cell production Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive a £1.2 million investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a project which will develop a faster, more...

Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board

Cambridge, UK, Oct 10 2018: Owlstone Medical (or the “Company”), a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, today announces the appointment of Dr. Richard A Yost to its Scientific Advisory Board. Dr. Yost, Professor and Head of Analytical Chemistry at the University of Florida, is an internationally...

Tuesday 9th October 2018

Resource and Environmental Consultants Ltd, a Concept Life Sciences Group company, strengthens senior team to support growth and development plans

Ged Sojka joins as National Operations Director in Geo-Environmental, Martin Lucass as Northern Geo-Environmental team leader, and Mike Armitage as Head of Ecology Manchester, UK, 09 October 2018: Resource and Environmental Consultants Ltd (REC), the UK environmental consultancy, part of the Concept Life Sciences Group, has announced the appointment of three new senior team members. Ged Soj...

Monday 8th October 2018

Aigenpulse strengthens management team with appointment of Chief Product Officer

Dr Satnam Surae will focus on the strategic development and growth of the Aigenpulse scientific data management platform in drug discovery Appointment supports company’s continued expansion, growing from 5 to 21 employees in 12 months Oxford, UK, 08 October 2018: Aigenpulse Ltd., (Aigenpulse), a company at the forefront of employing data technologies and advanced machine learn...

Tuesday 2nd October 2018

Scientists develop recombinant human antibody panel against snake venom.

Paper published in Nature Communications shows the potential of applying modern recombinant antibody technology to the blight of snake envenomation Collaboration between IONTAS, Cambridge, Instituto Clodomiro Picado (Universidad de Costa Rica), and Technical University of Denmark to develop fully human IgG antibodies that neutralise black mamba snake venom in vivo Cambridge, UK, San...

Arcis Biotechnology raises £1.25 million (USD $1.63 million) funding and opens further £0.5 million investment opportunity through Capital Cell.

£1.25 million already secured based on pre-money valuation of £18.2 million Additional funding will be used to further accelerate product development and company growth Daresbury, UK, 02 October 2018: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced the closing of a £1.25 million investment round and ...

Monday 1st October 2018

Evonetix partner with LioniX International to enable DNA synthesis at scale

Collaboration will focus on the development of a bespoke silicon array to enable high-throughput production of high-fidelity gene-length DNA DNA synthesis at this level will allow applications in the rapidly growing field of synthetic biology to become a reality CAMBRIDGE, UK, and ENSCHEDE, The Netherlands, 01 October 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge...

Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round

Investment will fund the global commercialization of Owlstone Medical’s Breath Biopsy® platform for early disease detection and precision medicine The first phase of the round, announced March 2018, raised $15 million (c.£11 million) and was led by Aviva Ventures and Horizons Ventures This second phase, attracting global interest and led by Horizons Ventures, raised...

Thursday 27th September 2018

Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies

Global investment firm backs growth plans for TTP Labtech Cambridge, UK, 27 September 2018: TTP Labtech Ltd, an international leader in the design and development of automated instrumentation and consumables for life science research is pleased to announce that investment from Battery Ventures has underpinned their aggressive growth plans.  Over the last 18 years TTP Labtech has suc...

Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology

Expedeon’s proprietary colloidal gold to be used for manufacturing of diagnostic lateral flow assays Expedeon’s InnovaCoat® GOLD to be assessed for increasing sensitivity of marketed assays Heidelberg, Germany and Cambridge, UK, 27 September 2018 – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced that the Company has signed a thr...

Tuesday 25th September 2018

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines Keele, Darlington and London, 25 September 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, today announced a collaboration with the Centre for Process Innovation (CPI), a UK-based techno...

Monday 24th September 2018

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

• First-to-market cell line-derived reference standard for myeloid blood cancers • Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes • Enables faster, more reliable and more cost-effective assay validation Cambridge, UK, 24 September, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “t...

Wednesday 19th September 2018

Novel deep learning drug discovery platform gets £1 million innovation boost

September 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens...

Tuesday 18th September 2018

Evonetix makes key appointments to support development of novel gene synthesis technology

CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthesis, announced today that it has expanded its team three-fold, following a successful series A round of £9 million ($12.3M) to support the development of the Company’s technology. The appointments include physicis...

Monday 17th September 2018

BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines Ajdovšcina, Slovenia, 17 September 2018: BIA Separations, a leading biochromatography development and manufacturing company, today announced the expansion of its s...

Sphere Fluidics introduces new Cyto-Mine Studio Software Suite

<!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style>

Metrion Biosciences makes senior appointments to strengthen its drug discovery leadership team.

Dr Edward Stevens appointed as Head of Drug Discovery, and Dr Andrew Lightfoot as Head of Medicinal Chemistry and Discovery Funding Cambridge, UK, 17 September 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced it has made two senior appointments to its management team.  Dr Edward Steve...

Friday 14th September 2018

Horizon Discovery Group plc Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader i...

Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors

Cambridge, UK, September 14 2018: Owlstone Medical Ltd (or the “Company”), a global diagnostics company developing a breathalyzer for early disease detection and precision medicine, announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director. Dr Richards is a serial entrepreneur and business angel with an established track record in founding and...

Wednesday 12th September 2018

Concept Life Sciences strengthens Analytical Services business with three senior appointments

Michelle Gale joins as Head of Customer Services, Dr Ben Cliff as Vice President of Operations, and Lorraine Bater as Regional Director of the South, UK Appointments support provision of routine testing, monitoring and specialist analysis services to life sciences, food & consumer services, and industrial and environmental services industries Manchester, UK, 12 September 2018: C...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks